
News
MedAdvisor (MDR) - FY25 and FY26 guidance with revenue of $93-99m for FY25
Proceeds from the recent capital raise will place MedAdvisor in a good position to capitalise on targeting organic revenue growth of circa. 15% and margin expansion for the consolidated group. In conjunction with running a target cost optimisation program, with approximately $12.8 million in savings are expected between FY24–